Fused heterocyclic compound

Details for Australian Patent Application No. 2005250285 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Seto, Masaki; Banno, Hiroshi; Taniguchi, Takahiko; Ishikawa, Tomoyasu

Agent Griffith Hack

Pub. Number AU-B-2005250285

PCT Pub. Number WO2005/118588

Priority 2004-165050 02.06.04 JP; 2005-058231 02.03.05 JP

Filing date 1 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 18 August 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 487/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118588 Priority application(s): WO2005/118588

18 August 2011 Application Accepted

  Published as AU-B-2005250285

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250308-Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds

2005250273-Propane-1,3-dione derivative or its salt